STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more

A U.S. judge rejected a bid to block ‌Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs